Amyris
PrivateLast Round
Debt
Feb 2, 2024
Est. Valuation
$644.73M
Total Funding Raised
$713.6M
Company Overview
Amyris is a synthetic biotechnology company that manufactures sustainable ingredients for the health and wellness, clean beauty, and flavor and fragrance markets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Fashion & Beauty, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amyris Comps
Public and private peers based on sector, stage, and business model.
Amyris Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 2, 2024 | ||||
| Bankruptcy | Aug 9, 2023 | ||||
| Private Placement | Dec 29, 2022 | ||||
| Debt | Sep 13, 2022 | ||||
| Follow-on Offering | Apr 9, 2021 | ||||
Private Placement | Jun 10, 2020 |
Key People
Founding team and executive leadership
Amyris Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Temasek | Series D, Convertible Debt |
| Cowen Private Investments | Follow-on Offering |
| The Westly Group | Series D |
| Khosla Ventures | Series B, Series C, Series D, Series A |
| Stifel, Nicolaus & Company, Incorporated | IPO |
| Wolverine Asset Management | Convertible Debt |
| Morgan Stanley | IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 4, 2025
Monthly visitors increased 62% MoM, reaching 9.9K.
- Feb 2, 2024
$160M debt round completed.
Amyris Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Amyris's valuation, stock price, and market status.
